| [1] |
Wen PY, Kesari S. Malignant Gliomas in Adults[J]. N Engl J Med, 20 08, 359(5): 492-507.
|
| [2] |
Scoccianti S, Magrini SM, Ricardi U, et al. Patterns of care and survival in a retrospective analysis of 1059 patients with glioblastoma multiforme treated between 2002 and 2007: a multicenter study by the Central Nervous System Study Group of Airo (Italian Association of Radiation Oncology)[J]. Neurosurgery, 2010, 67(2): 446-58.
|
| [3] |
Narayana A, Yamada J, Berry S, et al. Intensity-modulated radiotherapy in high-grade glioma: clinical and dosimetric results[J]. Int J Radiat Oncol Biol Phys, 2006, 64(3): 892-7.
|
| [4] |
Tanaka M, Ino Y, Nakagawa K, et al. High-dose conformal radiotherapy for supratentorial malignant glioma: a historical comparison[J]. Lancet Oncol, 2005, 6(12): 953-60.
|
| [5] |
Cardinale R, Won M, Choucair A, et al. A phaseⅡtrial of accelerated radiotherapy using weekly stereotactic conformal boost for supratentorial glioblastoma multiforme RTOG0023[J]. Int J Radiat Oncol Biol Phys, 2006, 65(5): 1422-8.
|
| [6] |
Tsien C, Moughan J, Michalski JM, et al. PhaseⅠthreedimensional conformal radiation dose escalation study in newly diagnosed glioblastoma: Radiation Therapy Oncology Group Trial 98 -03[J]. Int J Radiat Oncol Biol Phys, 2009, 73(3): 699-708.
|
| [7] |
Stieber VW, Mehta MP. Advances in radiation therapy for brain tumors[J]. Neurol Clin, 2007, 25(4): 1005-33.
|
| [8] |
Hasegawa M, Niibe H, Mitsuhashi N, et al. Hyperfraetionated and hvpofraetionated radiation therapy for human malignant dioma xenograft in nude mice[J]. Jpn J Cancer Res, 1995, 86(9): 879-84.
|
| [9] |
Xu X, Yang WZ, Gao L, et al. Optimizing the schedules of fractionated irradiation in subclinical tumors of malignantglioma[J]. Zhonghua Fang She Zhong Liu Xue Za Zhi, 2012, 21 (6): 563-6. [许新, 杨伟志, 高黎, 等. 恶性脑胶质瘤亚临床 肿瘤分割照射方案优化的实验研究[J]. 中华放射肿瘤学杂志, 20 12, 21(6): 563-6.]
|
| [10] |
Laperriere N, Zuraw L, Cairncross G, et al. Radiotherapy for newly diagnosed malignant gliomas in adults: a systematic rewiew[J]. Radiother Oncol, 2002, 64(3) :259-73.
|
| [11] |
Bucgner JC, Ballman KV, Burton GV, et al. Phase Ⅲ trial of carmustine and cisplatin compared with carmustine alone and standard radiation therapy or accelerated radiation therapy in patients with glioblastoma multiforme: North Central Cancer Treatment Group 93-72-52 and Southwest Oncology Group9503 Trials[J]. J Clin Oncol, 2006, 24 (24): 3871-9.
|
| [12] |
Prados MD, Wara WM, Sneed PK, et al. PhaseⅢtrial of accelerated hyperfractionation with or without difluromethylom ithine(DFMO) versus standard fractionated radiotherapy with or without DFMO for newly diagnosed patients with glioblastoma multiforme[J]. Int J Radiat Oncol Biol Phys, 2001, 49(1): 71-7.
|
| [13] |
Levin VA, Yung WK, Bruner J, et al. PhaseⅡ study of accelerated fractionation radiation therapy with carboplatin followed by PCV chemotherapy for the treatment of anaplastic gliomas[J]. Int J Radiat Oncol Biol Phys, 2002, 53(1): 58-66.
|
| [14] |
Hulshof MC, Schimmel EC, Andr ies Bosch D, et al. Hypofractionation in glioblastoma multiforme[J]. Radiother Oncol, 2000, 54(2) :143-8.
|
| [15] |
Sultanem K, Patrocinio H, Lambert C, et al. The use of hypofractionated intensity-modulated irradiation in the treatment of glioblastoma multiforme: preliminary results of a prospective trial[J]. Int J Radiat Oncol Biol Phys, 2004, 58(1): 247-52.
|
| [16] |
McAleese JJ, Stenning SP, Ashley S, et al. Hypofractionationated radiotherapy for poor prognosis malignant gliomas: mathed pair survival analysis with MRC controls[J]. Radiother Oncol, 2003, 67 (2): 177-82.
|
| [17] |
Liu YQ, Qian LT, Zhang HY, et al. Effect of Intensity-modulated Radiotherapy with Different Dose Fractionations on 58 Astrocytic Tumors[J]. Zhongguo Zhong Liu Lin Chuang, 2010, 37(7): 395-8. [刘云琴, 钱立庭, 张红雁, 等. 58例胶质瘤不同分割剂量调强放 疗疗效观察[J]. 中国肿瘤临床, 2010, 37(7): 395-8.]
|
| [18] |
Li SQ, Jiang XD, Wang QS, et al. The observation of different curative effect on conformal radiotherapy after conventional radiotherapy of malignant glioma[J]. Shandong Yi Yao, 2011, 51 (41): 37-8. [黎世秋, 蒋晓东, 王全善, 等. 恶性脑胶质瘤常规 放疗后适形放疗不同推量模式疗效观察[J]. 山东医药, 2011, 51 (41): 37-8.]
|
| [19] |
Roa W, Brasher PM, Banman G, et al. Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trial[J]. J Clin Oncol, 2004, 22 (9): 1583-8.
|
| [20] |
Nieder C, Andratschke N, Wiedenmann N, et al. Radiotherapy for high grade gliomas. Does altered fractionation improve ethe outcome? [J]. Strahlenther Onkol, 2004, 180(7): 401-7.
|
| [21] |
Minniti G, De Sanctis V, Muni R, et al. Hypofractionated radiotherapy followed by adjuvant chemotherapy with temozolomide in elderly patients with glioblastoma[J]. J Neurosurg, 2009, 91(1): 95-100.
|
| [22] |
Muni R, Minniti G, Lanzetta G, et al. Short-term radiotherapy followed by adjuvant chemotherapy in poor-prognosis patients with glioblastoma[J]. Tumori, 2010, 96(1): 60-4.
|
| [23] |
Panet-Raymond V, Souhami L, Roberge D, et al. Accelerated Hypofractionate intensity modulated radiotherapy with concurrent and adjuvant emozolomide for patients with glioblastoma multiforme：a safety and efficacy analysis[J]. Int J Radiat Oncol Biol Phys, 2009, 73(2): 473-8.
|
| [24] |
Yazici G, Cengiz M, Ozyigit G, et al. Hypofractionated stereotactic reirradiation for recurrent glioblastoma[J]. J Neurooncol, 2014, 20(1): 117-23.
|
| [25] |
De La Fuente Herman T, Ahmad And S, Vlachaki MT. Intensity modulated radiation therapy versus three dimensional conformal radiation therapy for treatment of high grade glioma: a radiobiological modeling study[J]. J Xray Sci Technol, 2010, 18 (4): 393-402.
|
| [26] |
Amelio D, Lorentini S, Schwarz M, et al. Intensity-modulated radiation therapy in newly diagnosed glioblastoma: a systematic review on clinical and technical issues[J]. Radiother Oncol, 2010, 97 (3): 361-9.
|
| [27] |
MacDonald SM, Ahmad S, Kachris S, et al. Intensity modulated radiation therapy versus three-dimensional conformal radiation therapy for the treatment of high grade glioma: a dosimetric comparison[J]. J Appl clin Med phys, 2007, 8(2): 47-60.
|
| [28] |
Li J, Zhang XP, He HT, et al. Glioma of intensity modulated radiation therapy (imrt) during the same period on 26 patients experience[J]. Zhongguo Shen Jing Zhong Liu Za Zhi, 2010, 8(2): 11 3-6. [李健, 张秀萍, 何海涛, 等. 胶质瘤的同期推量调强放射 治疗26例经验[J]. 中国神经肿瘤杂志, 2010, 8(2): 113-6.]
|
| [29] |
Cho KH, Kim JY, Lee SH, et al. Simultaneous integrated boost intensity-modulated radiotherapy in patients with high-grade gliomas[J]. Int J Radiat Oncol Biol Phys, 2010, 78(2): 390-7.
|
| [30] |
Moniazeb AM, Ayala D, Jensen C, et al. A phaseⅠdose escalation study of hypofractionated IMRT field-in-field boost for newly diagnosed glioblastoma multiforme[J]. Int J Radiat Oncol Biol Phys, 2012, 82(2): 743-8.
|
| [31] |
Iuchi T, Hatano K, Narit Y, et al. Hypofractionated high-dose irradiation for the treatment of malignant a strocytomas using simultaneous integrated boost technique by IMRT[J]. Int J Radiat Oncolo Biol Phys, 2006, 64(5): 1317-24.
|
| [32] |
Jastaniyah N, Murtha A, Pervez N, et al. PhaseⅠstudy of hypofractionated intensity modulated radiation therapy with concurrent and adjuvant temozolomide in patients with glioblastoma multiforme[J]. Radiat Oncol, 2013, 8: 38.
|
| [33] |
Ciammella P, Galeandro M, D’Abbiero N, et al. Hypofractionated IMRT for patients with newly diagnosed glioblastoma multiforme: a 6 year single institutional experience[J]. Clin Neurol Neurosurg, 2013, 115(9): 1609-14.
|
| [34] |
Lim YJ , Kim IH, Ha n TJ , e t a l . Hy p o f r a c t i o n a t e d chemoradiotherapy with temozolomide as a treatment option for glioblastoma patients with poor prognostic features[J]. Int J Clin Oncol, 2015, 20(1): 21-8.
|
| [35] |
Pashaki AS, Hamed EA, Mohamadian K, et al. Efficacy of high dose radiotherapy in post-operative treatment of glioblastoma multiform--a single institution report[J]. Asian Pac J Cancer Prev, 2014, 15(6): 2793-6.
|
| [36] |
Massaccesi M, Ferro M, Cilla S, et al. Accelerated intensity modulated radiotherapy plus temozolomide in patients with glioblastoma: a phaseⅠdose-escalation study (ISIDE-BT- 1) [J]. Int J Clin Oncol, 2013, 18(5): 784-91.
|
| [37] |
Chen C, Damek D, Gaspar LE, et al. PhaseⅠtrial of hypofractionated intensity-modulated radiotherapy with temozolomide for patients with newly diagnosed glioblastoma multiforme[J]. Int J Radiat Oncol Biol Phys, 2011, 81(4): 10 66-74.
|
| [38] |
Reddy K, Damek D, Gaspar LE, et al. PhaseⅡTrial of Hypofractionated IMRT With Temozolomide for Patients With Newly Diagnosed Glioblastoma Multiforme[J]. Int J Radiat Oncol Biol Phys, 2012, 84(3): 655-60.
|
| [39] |
Reddy K, Gaspar LE, Kavanagh BD, et al. Hypofractionated intensitymodulated radiotherapy with temozolomide chemotherapy may alter the patterns of failure in patients with glioblastoma multiforme[J]. J Med Imaging Radiat Oncol, 2014, 58(6): 714-21.
|
| [40] |
Iuchi T, Hatano K, Kodama T, et al. Phase 2 trial of hypofractionated high-dose intensity modulated radiation therapy with concurrent and adjuvant temozolomide for newly diagnos ed glioblastoma[J]. Int J Radiat Oncol Biol Phys, 2014, 88(4): 79 3-800.
|
下载:
